title: Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth.
abstract: Interactions between cancer cells and fibroblasts are crucial in cancer progression. We have previously shown that the aspartic protease cathepsin D (cath-D), a marker of poor prognosis in breast cancer that is overexpressed and highly secreted by breast cancer cells, triggers mouse embryonic fibroblast outgrowth via a paracrine loop. Here, we show the requirement of secreted cath-D for human mammary fibroblast outgrowth using a three-dimensional co-culture assay with breast cancer cells that do or do not secrete pro-cath-D. Interestingly, proteolytically-inactive pro-cath-D remains mitogenic, indicating a mechanism involving protein-protein interaction. We identify the low-density lipoprotein (LDL) receptor-related protein-1, LRP1, as a novel binding partner for pro-cath-D in fibroblasts. Pro-cath-D binds to residues 349-394 of the β chain of LRP1, and is the first ligand of the extracellular domain of LRP1β to be identified. We show that pro-cath-D interacts with LRP1β in cellulo. Interaction occurs at the cell surface, and overexpressed LRP1β directs pro-cath-D to the lipid rafts. Our results reveal that the ability of secreted pro-cath-D to promote human mammary fibroblast outgrowth depends on LRP1 expression, suggesting that pro-cath-D-LRP1β interaction plays a functional role in the outgrowth of fibroblasts. Overall, our findings strongly suggest that pro-cath-D secreted by epithelial cancer cells promotes fibroblast outgrowth in a paracrine LRP1-dependent manner in the breast tumor microenvironment.
authors.affiliation: IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, F-34298, France.
authors.forename: Mélanie
authors.initials: M
authors.lastname: Beaujouin
authors.forename: Christine
authors.initials: C
authors.lastname: Prébois
authors.forename: Danielle
authors.initials: D
authors.lastname: Derocq
authors.forename: Valérie
authors.initials: V
authors.lastname: Laurent-Matha
authors.forename: Olivier
authors.initials: O
authors.lastname: Masson
authors.forename: Sophie
authors.initials: S
authors.lastname: Pattingre
authors.forename: Peter
authors.initials: P
authors.lastname: Coopman
authors.forename: Nadir
authors.initials: N
authors.lastname: Bettache
authors.forename: Jami
authors.initials: J
authors.lastname: Grossfield
authors.forename: Robert E
authors.initials: RE
authors.lastname: Hollingsworth
authors.forename: Hongyu
authors.initials: H
authors.lastname: Zhang
authors.forename: Zemin
authors.initials: Z
authors.lastname: Yao
authors.forename: Bradley T
authors.initials: BT
authors.lastname: Hyman
authors.forename: Peter
authors.initials: P
authors.lastname: van der Geer
authors.forename: Gary K
authors.initials: GK
authors.lastname: Smith
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Liaudet-Coopman
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism*; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D002277:Carcinoma / Q000378:metabolism* / Q000473:pathology; D002402:Cathepsin D / Q000378:metabolism*; D048708:Cell Growth Processes; D002461:Cell Line, Transformed; D018920:Coculture Techniques; D004792:Enzyme Precursors / Q000378:metabolism*; D005260:Female; D005347:Fibroblasts / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000235:genetics / Q000378:metabolism*; D021962:Membrane Microdomains / Q000235:genetics; D051379:Mice; D019899:Paracrine Communication; D011485:Protein Binding; D054730:Protein Interaction Domains and Motifs / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics
chemical_list: D015703:Antigens, CD; D004792:Enzyme Precursors; C475476:LRP1 protein, human; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D034741:RNA, Small Interfering; C058345:procathepsin D; D002402:Cathepsin D
references.citation: J Biol Chem. 1991 Dec 15;266(35):23586-92
references.pmid: 1660878
references.citation: FASEB J. 2004 Dec;18(15):1920-1
references.pmid: 15469966
references.citation: Mol Cell Biol. 2008 May;28(9):2980-95
references.pmid: 18316405
references.citation: Oncogene. 2002 Aug 29;21(38):5951-5
references.pmid: 12185597
references.citation: Nat Rev Cancer. 2006 Oct;6(10):764-75
references.pmid: 16990854
references.citation: J Cell Biol. 1998 Mar 23;140(6):1535-41
references.pmid: 9508784
references.citation: J Thromb Haemost. 2003 Jul;1(7):1663-70
references.pmid: 12871303
references.citation: Cancer Res. 2007 Oct 15;67(20):9817-24
references.pmid: 17942912
references.citation: Cancer Lett. 2006 Jun 18;237(2):167-79
references.pmid: 16046058
references.citation: J Cell Biochem. 2005 Dec 1;96(5):1021-33
references.pmid: 16149055
references.citation: Genes Dev. 2001 Jan 1;15(1):50-65
references.pmid: 11156605
references.citation: J Biol Chem. 2002 Aug 30;277(35):32220-7
references.pmid: 12072442
references.citation: J Cell Biol. 1994 Feb;124(4):401-4
references.pmid: 8106541
references.citation: Nature. 2001 May 17;411(6835):375-9
references.pmid: 11357145
references.citation: Biomed Pharmacother. 2003 Oct;57(8):333-40
references.pmid: 14568227
references.citation: J Biol Chem. 2003 Oct 17;278(42):41182-8
references.pmid: 12888553
references.citation: Genomics. 2000 Oct 1;69(1):63-71
references.pmid: 11013076
references.citation: Nat Rev Cancer. 2004 Nov;4(11):839-49
references.pmid: 15516957
references.citation: Exp Cell Res. 2002 Jul 15;277(2):210-9
references.pmid: 12083803
references.citation: J Biol Chem. 2002 May 24;277(21):18736-43
references.pmid: 11907044
references.citation: Exp Cell Res. 1994 Nov;215(1):154-63
references.pmid: 7957663
references.citation: Cancer Res. 2009 Feb 1;69(3):879-86
references.pmid: 19176371
references.citation: J Biol Chem. 2002 May 3;277(18):15507-13
references.pmid: 11854295
references.citation: Br J Cancer. 1997;76(5):661-6
references.pmid: 9303368
references.citation: Cancer Res. 1985 Feb;45(2):709-16
references.pmid: 3881171
references.citation: Int J Cancer. 1996 May 16;66(4):441-52
references.pmid: 8635858
references.citation: J Biol Chem. 2004 Jan 16;279(3):2221-30
references.pmid: 14593097
references.citation: Sci Signal. 2008 Nov 25;1(47):ra15
references.pmid: 19036715
references.citation: J Cell Biol. 2005 Jan 31;168(3):489-99
references.pmid: 15668295
references.citation: Int J Oncol. 2002 Apr;20(4):761-7
references.pmid: 11894122
references.citation: Mol Cell. 2006 Aug;23(4):451-5
references.pmid: 16916634
references.citation: J Thromb Haemost. 2005 Aug;3(8):1884-93
references.pmid: 16102056
references.citation: EMBO J. 1993 Apr;12(4):1293-302
references.pmid: 8467789
references.citation: APMIS. 1999 Jan;107(1):86-95
references.pmid: 10190284
references.citation: Endocrinology. 1986 Apr;118(4):1537-45
references.pmid: 3948791
references.citation: Int J Biol Markers. 2005 Apr-Jun;20(2):103-11
references.pmid: 16011040
references.citation: Oncogene. 2003 Jun 5;22(23):3589-97
references.pmid: 12789267
references.citation: Cancer Res. 1989 Jul 15;49(14):3904-9
references.pmid: 2736531
references.citation: Trends Cardiovasc Med. 2004 Feb;14(2):55-60
references.pmid: 15030790
references.citation: Cancer Res. 2000 Feb 15;60(4):883-7
references.pmid: 10706099
references.citation: Oncogene. 2002 Aug 1;21(33):5127-34
references.pmid: 12140763
references.citation: Nature. 1990 Dec 20-27;348(6303):699-704
references.pmid: 1701851
references.citation: J Biol Chem. 2003 Aug 15;278(33):31401-11
references.pmid: 12782632
references.citation: Breast Cancer Res. 2003;5(3):R77-81
references.pmid: 12793904
references.citation: J Clin Invest. 2001 Sep;108(6):779-84
references.pmid: 11560943
references.citation: Int J Cancer. 1999 Jun 21;84(3):209-15
references.pmid: 10371335
references.citation: Cancer Res. 2005 Oct 15;65(20):9338-46
references.pmid: 16230396
references.citation: Cancer Res. 1988 Jul 1;48(13):3709-15
references.pmid: 2454153
references.citation: J Biochem. 2006 Mar;139(3):363-71
references.pmid: 16567401
references.citation: J Biol Chem. 2006 Jan 27;281(4):2120-7
references.pmid: 16303771
references.citation: J Biol Chem. 2005 May 6;280(18):17777-85
references.pmid: 15749709
references.citation: FEBS Lett. 2003 Dec 4;555(2):346-50
references.pmid: 14644440
references.citation: Oncol Rep. 2007 Feb;17(2):361-7
references.pmid: 17203175
references.citation: Oncogene. 2001 Oct 18;20(47):6920-9
references.pmid: 11687971
references.citation: Cancer Res. 2008 Jun 15;68(12):4666-73
references.pmid: 18559512
references.citation: J Cell Sci. 1998 Sep;111 ( Pt 17):2539-49
references.pmid: 9701553